190 related articles for article (PubMed ID: 12364438)
1. Fas and its ligand, caspases, and bcl-2 expression in gonadotropin-releasing hormone agonist-treated uterine leiomyoma.
Huang SC; Tang MJ; Hsu KF; Cheng YM; Chou CY
J Clin Endocrinol Metab; 2002 Oct; 87(10):4580-6. PubMed ID: 12364438
[TBL] [Abstract][Full Text] [Related]
2. Maintenance of increased Bcl-2 expression in uterine leiomyomas after GnRH agonist therapy.
Khurana KK; Singh SB; Tatum AH; Schulz V; Badawy SZ
J Reprod Med; 1999 Jun; 44(6):487-92. PubMed ID: 10394541
[TBL] [Abstract][Full Text] [Related]
3. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
Vu K; Greenspan DL; Wu TC; Zacur HA; Kurman RJ
Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
[TBL] [Abstract][Full Text] [Related]
4. Effect of GnRH analogues on apoptosis and expression of Bcl-2, Bax, Fas and FasL proteins in endometrial epithelial cell cultures from patients with endometriosis and controls.
Bilotas M; Barañao RI; Buquet R; Sueldo C; Tesone M; Meresman G
Hum Reprod; 2007 Mar; 22(3):644-53. PubMed ID: 17092985
[TBL] [Abstract][Full Text] [Related]
5. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease.
Giordano C; Richiusa P; Bagnasco M; Pizzolanti G; Di Blasi F; Sbriglia MS; Mattina A; Pesce G; Montagna P; Capone F; Misiano G; Scorsone A; Pugliese A; Galluzzo A
Thyroid; 2001 Mar; 11(3):233-44. PubMed ID: 11327614
[TBL] [Abstract][Full Text] [Related]
7. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
Mizutani T; Sugihara A; Nakamuro K; Terada N
J Clin Endocrinol Metab; 1998 Apr; 83(4):1253-5. PubMed ID: 9543151
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by linoleic acid is associated with the modulation of Bcl-2 family and Fas/FasL system and activation of caspases in AGS human gastric adenocarcinoma cells.
Kwon JI; Kim GY; Park KY; Ryu CH; Choi YH
J Med Food; 2008 Mar; 11(1):1-8. PubMed ID: 18361731
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas.
Luo HY; Yu SF; Li TJ
Int J Oral Maxillofac Surg; 2006 Aug; 35(8):750-5. PubMed ID: 16690252
[TBL] [Abstract][Full Text] [Related]
11. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
[TBL] [Abstract][Full Text] [Related]
12. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
13. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas.
Lee SH; Shin MS; Lee JY; Park WS; Kim SY; Jang JJ; Dong SM; Na EY; Kim CS; Kim SH; Yoo NJ
J Pathol; 1999 Jun; 188(2):207-12. PubMed ID: 10398166
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis in uterine epithelium and decidua in response to implantation: evidence for two different pathways.
Joswig A; Gabriel HD; Kibschull M; Winterhager E
Reprod Biol Endocrinol; 2003 May; 1():44. PubMed ID: 12801416
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in human uterine leiomyomas.
Martel KM; Ko AC; Christman GM; Stribley JM
Semin Reprod Med; 2004 May; 22(2):91-103. PubMed ID: 15164304
[TBL] [Abstract][Full Text] [Related]
16. Cell death signaling in the cerebellum in Creutzfeldt-Jakob disease.
Puig B; Ferrer I
Acta Neuropathol; 2001 Sep; 102(3):207-15. PubMed ID: 11585244
[TBL] [Abstract][Full Text] [Related]
17. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in chronic adult periodontitis analyzed by in situ DNA breaks, electron microscopy, and immunohistochemistry.
Gamonal J; Bascones A; Acevedo A; Blanco E; Silva A
J Periodontol; 2001 Apr; 72(4):517-25. PubMed ID: 11338305
[TBL] [Abstract][Full Text] [Related]
19. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy.
Khan KN; Kitajima M; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H
Hum Reprod; 2010 Mar; 25(3):642-53. PubMed ID: 20008888
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms involved in GnRH analogue-related apoptosis for uterine leiomyomas.
Bifulco G; Miele C; Pellicano M; Trencia A; Ferraioli M; Paturzo F; Tommaselli GA; Beguinot F; Nappi C
Mol Hum Reprod; 2004 Jan; 10(1):43-8. PubMed ID: 14665705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
